Cas:93553-81-2 2-(3,4-Dichlorophenyl)succinic acid manufacturer & supplier

We serve Chemical Name:2-(3,4-Dichlorophenyl)succinic acid CAS:93553-81-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(3,4-Dichlorophenyl)succinic acid

Chemical Name:2-(3,4-Dichlorophenyl)succinic acid
CAS.NO:93553-81-2
Synonyms:2-(3,4-dichlorophenyl)butanedioic acid
Molecular Formula:C10H8Cl2O4
Molecular Weight:263.07400
HS Code:2917399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:370.9ºC at 760 mmHg
Density:1.555g/cm3
Index of Refraction:1.601
PSA:74.60000
Exact Mass:261.98000
LogP:2.63630

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-(3,4-dichlorophenyl)butanedioic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(3,4-dichlorophenyl)butanedioic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(3,4-dichlorophenyl)butanedioic acid Use and application,2-(3,4-dichlorophenyl)butanedioic acid technical grade,usp/ep/jp grade.


Related News: ��No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,�� said Kristen Devito, Global Director, Catalent Clinical Supply Services. 2-(3,4-Dichlorophenyl)succinic acid manufacturer At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth. 2-(3,4-Dichlorophenyl)succinic acid supplier ��No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,�� said Kristen Devito, Global Director, Catalent Clinical Supply Services. 2-(3,4-Dichlorophenyl)succinic acid vendor It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance. 2-(3,4-Dichlorophenyl)succinic acid factory It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.